| | |

Detecting Mesothelioma by Smell: A Promising Future

Detecting Mesothelioma by SmellEarly cancer detection can be difficult, but there is a promising history of research on detecting mesothelioma by smell.

A new study suggests that a change in a patient’s body odor may be used for early malignant pleural mesothelioma detection. This holds tremendous hope for early treatment.

Right now, pleural mesothelioma detection relies heavily on various clinical tests. These tests often include radiography, CT, MRI, ultrasound, and biopsy. All of these technologies and methods are effective. However, several are invasive, expensive, time-consuming, or limited to large hospital settings.

In an article in BBA – Reviews on Cancer, researchers explore how body odor can detect malignant pleural mesothelioma. The team says the research on detecting mesothelioma by smell is promising. Nevertheless, a more extensive global research effort is needed.

Linking Cancer Detection and Body Odor

There has been a growing interest in finding alternative early cancer detection methods. Preferably those which use less invasive and less expensive methods.

Cancer often alters body odor. Scientists have been working for decades on identifying the individual signatures of cancer, including their smell, in the war against mesothelioma. In a recent study, French scientists from the Centre for Ecological and Evolutionary Cancer Research reviewed 208 studies between 1984 and 2020.

Scientists have been trying to identify individual compounds in body odor smells to distinguish between healthy patients and those with cancer. Over the last 74 years, more than 784 different compounds have been identified. The presence of these odor compounds in mesothelioma patients raises questions about the link between body odor and cancer.

Over 60% of these studies analyzed lung cancer odors. Among 28 compounds identified, only two were specific to lung cancer. The compounds 1-propanol and pentane were found in most lung cancer publications. However, there is still more research to be done to confirm the specific value of these compounds as biomarkers in mesothelioma diagnosis.

Detecting Mesothelioma by Smell

Over the last 74 years, five publications have explored the use of body odor in the early detection of malignant pleural mesothelioma. Two studies identified ten compounds from the patient’s breath. Three additional studies used an electronic nose to identify additional compounds. However, no compound was shared between the publications.

Twenty-eight common odor compounds were identified in most studies. This includes those studies which focused on detecting mesothelioma by smell. Ten compounds specific to malignant pleural mesothelioma were identified.

Humans vs. Animals: Dogs, Mice, and Insects

Different techniques have been used to detect body odor changes in cancer patients. These most often include an electronic nose.

Previous research has shown that animals, including dogs and mice, can detect cancer by smell with close to 100% sensitivity. Even the use of insects may be possible for detecting mesothelioma by smell.

A Promising Future for Early Cancer Detection

According to Flora Gouzerh from the Centre for Ecological and Evolutionary Cancer Research, “The use of noses, whether animal or electronic, can be considered as a very promising technique for the detection of odor variation linked to cancer.”

Despite this promising research on detecting mesothelioma by smell, there is still a very long road ahead. No definitive answer currently exists. However, recent enthusiasm in the field gives hope that these techniques will diagnose cancer earlier.

Sources:

Gouzerh, F., Bessière, J. M., Ujvari, B., Thomas, F., Dujon, A. M., & Dormont, L. (2022). Odors and cancer: Current status and future directions. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer1877(1), 188644. https://doi.org/10.1016/j.bbcan.2021.188644

Similar Posts

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • |

    Teacher’s Diagnosis Highlights Mesothelioma Risk in Schools

    A recent mesothelioma diagnosis in the UK once again dramatically highlights the fact that even a small amount of asbestos can be deadly. Sixty-three-year-old school teacher Marion Potts of Brockenhurst died of mesothelioma in a Southampton hospital in June. According to an article in The Mirror, the Coroner recorded a verdict of “death from an industrial disease” after hearing evidence last week that Potts actually saw asbestos dust being released when she pinned work on the classroom walls. Most recently, Potts was head of the English department at Romsey School in Hampshire until her retirement two years ago. Mesothelioma is a growing threat among school teachers, administrators, maintenance workers, and even students in British schools. A government report released last…

  • |

    Mesothelioma Blood Test May Be Possible

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Micro-RNAs May Offer New Way to Fight Mesothelioma

    Scientists at one of the world’s top mesothelioma research centers, the Asbestos Diseases Research institute in Sydney, Australia, say that restoring the expression of certain micro RNAs in the cells of mesothelioma patients may offer a new way to fight the disease. A microRNA is a small RNA molecule which is involved in the regulation of gene expression. According to a new report in the Annals of Oncology, the Australian scientists found reduced expression of the micro RNA-15 family (miR-15/16) in the cells of mice with mesothelioma. “When malignant pleural mesothelioma cell lines were compared with the normal mesothelial cell line MeT-5A, the downregulation of miR-15/16 was 2- to 10-fold,” they report. This finding is consistent with previous cancer research…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • | |

    Treatment Uses Herpes Virus to Shrink Mesothelioma Tumors

    Researchers at a hospital in Sheffield, England are testing a potential new mesothelioma treatment based on the same virus that causes herpes. The small-scale trial is the first in the world to test the modified herpes simplex virus, HSV1716, in human mesothelioma patients. HSV1716 has been genetically engineered to infect and kill cancer cells without harming healthy cells. In laboratory studies on mesothelioma and some other cancers, it has been shown to be effective at shrinking tumors while causing limited toxicity. Just as significantly, HSV1716 increased survival rates among mice with various human cancers. The Phase I/II trial at Sheffield Experimental Cancer Medicine Centre is the next stage in development of HSV1716 as a viable mesothelioma treatment. The goal of…